carbapenems has been researched along with sq 109 in 1 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (sq 109) | Trials (sq 109) | Recent Studies (post-2010) (sq 109) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 58 | 3 | 41 |
| Protein | Taxonomy | carbapenems (IC50) | sq 109 (IC50) |
|---|---|---|---|
| Geranylgeranyl pyrophosphate synthase | Homo sapiens (human) | 4.5 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 5.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nuermberger, EL; Spigelman, MK; Yew, WW | 1 |
1 review(s) available for carbapenems and sq 109
| Article | Year |
|---|---|
Current development and future prospects in chemotherapy of tuberculosis.
Topics: Adamantane; Animals; Antitubercular Agents; Carbapenems; Clinical Trials as Topic; Diarylquinolines; Drug Delivery Systems; Ethylenediamines; Fluoroquinolones; Humans; Isonicotinic Acids; Mice; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Patient Compliance; Pyrroles; Quinolines; Rifamycins; Tuberculosis, Pulmonary | 2010 |